Completed NA INTERVENTIONAL 8-arm NCT02090374

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen: Monophosphoryl lipidA, Poly-inosine-cytosine, Poly-inosine-cytosine Stabilised With Poly-L-lysine and Carboxymethylcellulose, Resiquimod, Tuberculin and Timothy Grass Pollen

Sponsor: Imperial College London

Conditions Allergic Rhinitis Asthma Latent Tuberculosis

Interventions Poly I:C Poly ICLC R848 Timothy Grass Pollen Tuberculin Vitamin D

Updated 9 times since 2017 Last updated: Nov 3, 2021 Started: Mar 31, 2014 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Allergic Rhinitis and Asthma, this trial is completed. The trial is conducted by Imperial College London and has accumulated 9 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College London

Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paddington, United Kingdom